<DOC>
	<DOCNO>NCT00561340</DOCNO>
	<brief_summary>The purpose study see supplement calorie Pediasure effective maintaining height , weight , BMI percentiles young child 2 year treatment ADHD medication .</brief_summary>
	<brief_title>Study Effect Calorie Supplementation Growth Young Children ADHD Medication</brief_title>
	<detailed_description>This pilot study evaluate effect caloric supplementation maintenance growth parameter two year open-label atomoxetine treatment 5 6 year old child ADHD . The study ass efficacy caloric supplementation maintain baseline percentile height , weight , body mass index ( BMI ) . Patients randomly assign receive either PediaSure caloric supplementation , supplementation . Secondary aim include assess tolerability efficacy long-term , open-label atomoxetine treatment 5 6 year old child ADHD , obtain adequate pilot data regard safety , efficacy , potential effect atomoxetine growth parameter order submit multisite R01 adequately assess atomoxetine treatment effect young child ADHD .</detailed_description>
	<criteria>Children participate 8 week DBPC trial atomoxetine ( 1K23MH066127 ) wish participate longterm , open label trial atomoxetine . Parents patient must able attend regular study visit . Visits schedule every 30 day first 6 month every 60 day next 18 month . Children alternate medication due inefficacy intolerability atomoxetine may still participate . Parents unwilling provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Growth</keyword>
	<keyword>Atomoxetine</keyword>
	<keyword>Pediasure</keyword>
</DOC>